Edwin den Braber

Medical Director Europe Middle East Africa (EMEA), Covidien

More than 15 years in the pharmaceutical and medical device industry, with a R&D, medical marketing, and clinical experience. Performed contract and basic scientific research in field of tissue engineering, implants, wound healing, tissue modulation/ modification (Medtronic, Cordis, J&J, Dow Corning, Smith&Nephew, Astra Tech, Branemark). In the pharmaceutical industry a significant track record in medical marketing, pharmacoeconomics, and clinical/ medical affairs; all stages of clinical/ product development, ranging from pre Phase I studies to registration and reimbursement, portfolio and life cycle management strategies (including post-patent generic sustainability). Past and present areas of expertise: GE, ENT, asthma, diabetes, antibiotics, virology, immunology, neurology, addiction treatment, CNS, CV, oncology, surgerical and ablative techniques. Specialties: Clinical strategy development, medical marketing strategy development, pharmacoeconomics, communication strategies, KOL management